Sun Pharma shares rally after earnings beat boosts investor confidence

Sun Pharma shares jumped sharply after the company reported strong quarterly earnings, beating market expectations. Revenue growth was supported by improved specialty portfolio performance and stable US generics pricing. Profit margins expanded due to operating leverage and cost controls. Investors welcomed management’s outlook on new launches and pipeline progress, pushing the stock higher amid broader market volatility following upbeat guidance and positive analyst commentary globally.